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Abstract
Background: It remains unclear to what extent treatment-related gains in posttraumatic stress disorder (PTSD)
symptoms translate to improvements in broader domains of personal wellbeing, such as community connectedness,
life achievement and security. We sought to determine whether: 1. personal wellbeing improves during the course of a
treatment program and 2. changes in core symptom domains (PTSD, anxiety and depression) were associated with
improvements in overall personal wellbeing.
Methods: Participants (N = 124) completed the PTSD Checklist, the Depression and Anxiety Stress Scales and the
Personal Wellbeing Index at the start and end of a 4-week Trauma Focused CBT residential program, as well as 3- and
9-months post-treatment.
Results: Personal wellbeing improved significantly across the 9-months of the study. Generalised estimating equations
analyses indicated that (older) age and improvements in PTSD and depressive symptoms were independent predictors
of personal wellbeing across time.
Conclusions: Although personal wellbeing improved in tandem with PTSD symptoms, the magnitude of
improvement was small. These findings highlight a need to better understand how improvements in personal
wellbeing can be optimised following PTSD treatment.
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Background
Individuals with posttraumatic stress disorder (PTSD)
report high levels of dissatisfaction across multiple life
domains including physical health [1] and social and
occupational functioning [2]. It is generally assumed that
evidence-based interventions for PTSD, if effective,
should also lead to broader improvements in life satis-
faction [3].
Evidence suggests that self-rated quality of life in those
with PTSD improves in tandem with symptom improve-
ment during psychological [3] and pharmacological [4]
treatment. However, many of these studies focused on
health-related quality of life (e.g., physical and mental
health quality of life as assessed by measures such as
the Short Form Health Survey [5]). Notwithstanding
the overlap with symptom measures, a reliance on
disability-focused measures may have perpetuated an
assumption that quality of life and wellbeing are
synonymous with the absence of impairment. There
thus remains a need for a more comprehensive
assessment of quality of life in relation to PTSD treat-
ment if the full benefits of PTSD treatment are to be
adequately understood.
Personal wellbeing refers to the subjective dimension
of quality of life [6]. In addition to the physical and
mental health domains of quality of life, the notion of
personal wellbeing captures a broader range of dimen-
sions including perceptions of one’s standard of living,
life achievement, quality of personal relationships,
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perceived safety, community engagement and future se-
curity [6]. Furthermore, the concept of personal well-
being incorporates the possibility that an individual
might thrive rather than simply lack disability.
Overall life satisfaction is a similar concept to that
of personal wellbeing and appears to be relatively low
in individuals with PTSD [7]. However, there remains
a relative absence of research that has used measures
capturing a broad range of domains of personal well-
being in treatment people receiving treatment for
PTSD (such as relationship satisfaction, perceived
safety, etc). For instance, the few studies that have in-
vestigated changes in either life satisfaction or per-
sonal wellbeing during PTSD treatment, have typically
focused only on one specific domain, such as spiritual
wellbeing (e.g., [8]). An exception was a treatment
trial of venlafaxine versus sertraline in addition to
psychotherapy for refugees with PTSD, which re-
ported small to medium-size improvements in well-
being from pre to posttreatment, but did not include
a follow-up assessment to determine whether the ben-
efits persisted [9]. Investigation of whether improve-
ments in perceived wellbeing persist is important for
ensuring that changes in perceived wellbeing are reli-
able and remain once individuals complete treatment
programs and return to their home environments.
Improving our understanding of these processes has
the potential to provide a deeper understanding of
the broader benefits of PTSD treatment beyond
symptoms alone. For example, even though there is
increasing evidence to suggest that symptomatic
improvement persists following treatment, it remains
unclear whether this also applies for any improve-
ments in personal wellbeing. There are various path-
ways by which psychological therapies could affect
changes in wellbeing, one being an increased sense of
self-efficacy that might arise from strategies that pro-
mote mastery over one’s symptoms.
The purpose of the present study was to investigate
whether a four-week residential group treatment pro-
gram for PTSD is associated with improvements in
personal wellbeing in addition to symptoms of PTSD.
Consistent with findings regarding the similar but dis-
tinct concept of quality of life [3], we hypothesized
that improvements in personal wellbeing would im-
prove in tandem with improvements in PTSD symp-
toms. We also wanted to determine to what extent
changes in other core overlapping symptom domains
(such as anxiety and depression) were associated with
overall personal wellbeing. The program includes a 3-
and 9-month review of client progress, with the 9-
month assessment point being the final scheduled
follow-up appointment and the primary endpoint of
the present study.
Method
One hundred and twenty-four participants (Mean age =
45.5 years, SD = 10.3; 19.4% female [n = 24]) were
recruited from an inpatient residential PTSD treatment
program between July 2009 and October 2015. All par-
ticipants had a primary diagnosis of PTSD according to
the Clinician Administered PTSD Scale for DSM-IV
(CAPS; [10]). Individuals with a current substance use
disorder identified either at interview or from the Alco-
hol Use Identification Test (AUDIT; [11]) are excluded
from the treatment program. The study was approved by
the St John of God Health Care Human Research Ethics
Committee (ref 839).
Treatment
All participants were attending their first four-week resi-
dential group-based treatment program for PTSD. The
majority of group participants were funded to attend the
program through worker’s compensation claims (57.9%
who were mostly former emergency services workers),
by the Department of Veteran’s Affairs (27.8%) or the by
Australian Defence Force (7.9%), with only a small mi-
nority supported through private health insurance
(6.3%).
The group program (five days per week for four
weeks) included the following components: (i) psychoe-
ducation about PTSD, (ii) arousal reduction strategies,
(iii) cognitive restructuring, (iv) exploration of trauma
themes such as safety, trust, and power/control consist-
ent with cognitive processing therapy interventions [12]
and (v) discharge planning. Concurrent with the group
intervention, participants also attended individual ther-
apy sessions twice a week where prolonged imaginal ex-
posure therapy was conducted. The program included a
3- and 9-month review of client progress.
Measures
The following self-report measures were administered.
The 42-item version of the Depression Anxiety Stress
Scales (DASS-42; [13]) was administered. The DASS-42
have been shown to have good internal consistency
(Cronbach α’s ranging from 0.89 to 0.96; [14]), strong
convergent and discriminant validity [15], as well as fa-
vorable test-retest reliability [14].
The Posttraumatic Stress Disorder Checklist for
DSM-IV Civilian version (PCL; [16]) was used to
assess PTSD symptoms. The PCL is a 17-item meas-
ure of current PTSD symptoms. It is strongly corre-
lated with interview-based measures of PTSD, is able
to effectively discriminate those with and without a
PTSD diagnosis [16] and appears to have sound
internal consistency and test-retest reliability [17].
The internal consistency (Cronbach’s α) for the PCL
in the present sample was 0.91.
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The Personal Wellbeing Index (PWI) is a 7-item scale
[6]. The items include standard of living, personal
health, life achievement, personal relationships, personal
safety, community connectedness and future security. It
has an eighth item pertaining to satisfaction with one’s
spirituality or religion; however, completion of this item
is optional, thus total scores for the present study were
derived from summing the first seven items. Each item
is rated on a 10-point scale ranging from “No satisfac-
tion at all” (0) to “Completely satisfied” (10), such that
higher scores reflect greater levels of personal wellbeing.
The scale has sound convergent validity with similar
measures of wellbeing [18]. The mean score on the PWI
in a large Australian community sample was 75.3 (for
the 7-item version; [19]). The internal consistency
(Cronbach’s α) for the PWI in the present sample was
0.84.
Other self-report measures are routinely administered
as part of an accreditation process for the program.
However, these measures were not relevant to the
current research question and so are not reported here.
Data analysis
Descriptive statistics (frequency, means, and standard
deviation) were calculated for all key variables using
SPSS 24.0. Repeated measures ANOVAs withpost-hoc
pairwise t-test comparisons (using a Bonferrroni adjust-
ment) were used to determine which variables changed
significantly across time.
Generalized Estimating Equations (GEE) were used to
determine which variables predicted PWI total score.
The GEE approach allows estimation of regression coef-
ficients that reflect the longitudinal relation between a
predictor variable and an outcome variable [20]. In con-
trast to linear mixed model approaches, the GEE ap-
proach makes fewer assumptions about the data. For
instance, the GEE approach depends only on correct
specification of the mean of the outcome (given the co-
variates), not necessarily on the joint distribution of both
observed data and random effects (as a linear mixed
model approach does; [21]). The GEE approach also al-
lows inference at the population rather than individual
level. Gender was included as a factor and age, PCL total
score, and DASS Depression, Anxiety and Stress sub-
scales included as covariates. Gender was included on
the basis that women with PTSD report different trauma
histories to those experienced by men and given that
PTSD appears to impact the quality of life of women in
potentially different ways [22]. Age was included on the
basis that some domains of wellbeing, such as percep-
tions of life achievement, could conceivably be related to
age. In accordance with the recommendations of Twisk
[20], we ran GEE models both with and without time
point in the model, but we discuss findings for the
model that includes time given that time point can
potentially confound the relation between time-
dependent covariates and PWI score.
Goodness of fit tests are not available for GEE ana-
lyses; however, comparison of the Quasi likelihood under
Independence model Criterion (QIC) values were com-
pared for three correlation structures: unstructured,
exchangeable and AR(1), with AR(1) providing the low-
est value (29,938.36). Thus, results for the exchangeable
correlation structure are presented.
Results
Data were available for N = 124 at the start of treatment;
n = 115 (91.9%) participants at the end of residential
treatment and for n = 80 (64.5%) at the 9-month follow-
up. Participants who did and did not complete the post-
treatment and 9-month follow-up questionnaires did not
differ significantly on any demographic variable or on
pretreatment PCL, DASS Anxiety, DASS Stress or PWI
scores. DASS Depression scores were an exception, with
lower pretreatment DASS Depression scores for those
with complete pretreatment data at posttreatment
(Means = 22.0 [SD = 9.6] vs 30.9 [SD = 7.2); t = 2.85, df =
122, p = 0.005) and 9-month follow-up (Means = 20.9
[SD = 9.47] vs 26.07 [SD = 9.47]; t = 2.92, df = 122, p =
0.004) respectively.
Pretreatment mean PWI total scores (27.85) were well
below the mean of the broader Australian community
(75.3 for the 7-item version; t = 48.3, df = 123, p < 0.001;
[19]) indicating lower overall perceived personal
wellbeing.
There was a significant main effect of change in PWI
scores across the nine months although the magnitude
of improvement was small (F (3, 228) = 5.11, p = 0.002,
ηp
2 = 0.06). The only significant pairwise comparison in-
dicated an improvement in PWI scores from pre to post-
treatment (from a mean of 27.85 to 32.27; p < 0.0001).
Table 1 summarizes the scores on other key question-
naires at pretreatment, posttreatment, 3-month and 9-
month follow-up. There were significant main effects for
DASS Depression (F(3, 219) = 12.45, p < 0.0001), DASS
Stress (F(3, 216) = 11.27, p < 0.0001) and PCL (F(3, 222)
= 9.40, p < 0.0001) scores. The significant decrease in
PCL scores from pre to posttreatment indicates that the
active phase of treatment was beneficial in reducing
PTSD symptoms (from a mean of 62.78 to 56.93; p <
0.0001). However, across the follow-up period, from
posttreatment to 3-month and 9-month follow-ups re-
spectively, PCL scores remained consistent and did not
appear to change further from posttreatment levels (all
pairwise p’s > 0.05). The DASS Depression and Stress
subscale scores also improved from pretreatment to
posttreatment (from a mean of 20.66 to 16.12, p < 0.0001
and 26.71 to 21.26, p < 0.0001 for DASS Depression and
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Stress respectively). However, both DASS Depression
and DASS Stress scores increased from posttreatment to
the 3-month (from a mean of 16.12 to 21.14, p < 0.0001
for DASS depression; 21.26 to 25.62, p < 0.0001 for
DASS Stress) and 9-month follow-ups respectively (from
a mean of 16,12 to 21.93, p < 0.001 for DASS Depres-
sion; 21.26 to 25.96, p < 0.0001 for DASS Stress). There
were no significant changes in DASS Anxiety scores
across the nine months of the study and all pairwise
comparisons were not significant.
Generalised estimating equations (GEE) analyses
The results of the GEE analyses are summarized in
Table 2. PCL total scores, DASS Depression, and age
were each significant predictors of PWI scores. De-
creases in PCL total and DASS depression were signifi-
cant predictors of increased (improved) PWI scores as
well as (older) age. When controlling for other variables,
time point was not a significant predictor of PWI scores.
We note that the overall pattern of results was the same
when timepoint was (Table 2) and was not included in
the model (Additional file 1: Table S1) supporting the
role of assessed change in other variables as accounting
for the observed change in PWI scores.
Given that there is some degree of overlap between
two of the items of the PWI (pertaining to perceived
safety and future security) and PTSD symptoms, we re-
ran the analyses after excluding these items, noting that
the internal consistency of the PWI remained high at
0.77, 0.82 & 0.87 at pretreatment, posttreatment and 9-
month follow-up, respectively. The overall pattern of re-
sults for the GEE analysis was the same in that changes
in PCL, DASS-Depression and age each independently
predicted changes in PWI scores.
Discussion
There are three key findings from the present study.
First, individuals seeking treatment for PTSD reported
low levels of personal wellbeing. This finding is consist-
ent with reports of low levels of life satisfaction among
individuals with PTSD [23]. There are also broad paral-
lels with findings from studies of similar constructs in
Table 1 Means (SD) for symptom measures and perceived wellbeing at pretreatment, posttreatment, 3-month and 9-month follow-
up
(a) Pretreatment (b) Posttreatment (c) 3-month follow-up (d) 9-month follow-up Pairwise
significant differencesaMean (SD) Mean (SD) Mean (SD) Mean (SD)
DASS 21 – Depression 20.66 (9.48) 16.12 (9.42) 21.14 (10.24) 21.93 (10.08) a > b, b < c, b < d
DASS 21 – Anxiety 17.00 (8.42) 15.78 (8.22) 16.75 (8.09) 17.16 (8.65) ns
DASS 21 – Stress 26.71 (9.38) 21.26 (8.83) 25.62 (8.43) 25.96 (7.98) a > b, b < c, b < d
PCL 62.78 (11.59) 56.93 (11.66) 56.50 (12.77) 57.31 (11.72) a > b, a > c, a > d
PWI 27.85 (11.70) 32.27 (11.12) 29.88 (11.92) 30.49 (12.43) a < b
DASS 21 Depression and anxiety stress scales – 21 items, PCL Posttraumatic Stress Disorder Checklist for DSM-IV Civilian version
aDifferent subscripts correspond to p < 0.05 following Bonferroni pairwise corrections for post-hoc comparisons
Table 2 Generalized Estimating Equations (GEE) results (N = 124)
95% Wald confidence interval
B Std Error Lower Upper
Intercept 45.90 3.60 38.85 52.94
PCL total −0.26 0.05 −0.37 − 0.16
DASS Depression −0.39 0.08 −0.53 − 0.24
DASS Anxiety −0.06 0.10 −0.26 0.13
DASS Stress −0.04 0.08 −0.20 0.12
Age 0.19 0.06 0.07 0.30
Timepoint 4 (9mth follow-up) 1.00 1.06 −1.08 3.09
Timepoint 3 (3mth follow-up) −0.33 1.03 −2.34 1.70
Timepoint 2 (posttreatment) −0.27 0.95 −2.13 1.59
Timepoint 1 (Index: pretreatment) 0
Gender (Male) −0.81 2.36 −5.42 3.81
Gender (Index: Female) 0
DASS Depression and Anxiety Stress scales, PCL Posttraumatic symptom checklist for DSM-IV
A greater PWI score reflects a greater level of personal wellbeing
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PTSD, such as self-reported health-related quality of life,
which have indicated perceived impairments which go
beyond psychological symptoms themselves.
Second, there were significant improvements in PWI
scores across the 9-months of the study, although these
were only small in magnitude and did not remain signifi-
cant once changes in other variables (such as PTSD
symptoms) were accounted for. This relative persistence
of low levels of perceived personal wellbeing may be due
to the broad range of challenges faced by participants in
our sample who were in many cases transitioning from
military and emergency services careers to distinctly dif-
ferent roles. These transitions may impact one’s percep-
tions of standard of living, life achievement and
community connectedness [24, 25], none of which were
an explicit focus of the treatment program. Other stud-
ies that have investigated the benefits of interventions to
boost social connectedness and awareness of positive
emotions indicate that personal wellbeing may improve
when these are explicit aims for treatment [25].
Third, our results also suggest that improved perceived
personal wellbeing is associated with older age, and im-
provements in PTSD and depressive symptoms. This is
consistent with findings regarding the similar construct
of quality of life [26]. Given that both depression and
PTSD are thought to be characterised in part by dis-
torted cognitions about the self, the world and the future
[27, 28], it is not surprising that improvement in depres-
sion and PTSD symptoms might be associated with
changes in perceived personal wellbeing. For instance,
depressed individuals have been demonstrated to hold a
pervasive and general negative outlook with a tendency
to attribute negative events to stable, internal and global
factors [29] which could conceivably influence their rat-
ings of personal wellbeing.
The personal wellbeing of individuals seeking treat-
ment for PTSD may possibly be improved in either of
two ways. First, our results suggest that improvements
in symptoms of depression and PTSD may independ-
ently lead to improvements in wellbeing, albeit, to a
small extent. This holds particular promise in the case of
depression. As noted, in the present study, depression
symptoms intensified preceding the 3 month and
9 month follow-ups: If specific interventions could pre-
empt these setbacks then there may also be associated
benefits for personal wellbeing. Second, to the extent
that the treatment program focused on improvements in
PTSD symptoms, there remains the possibility that add-
itional improvements in personal wellbeing may be
achieved by including approaches from personal well-
being therapy [30], or other adjunctive interventions.
The implications of these current findings need to be
considered in light of the study’s limitations. Improve-
ment in PTSD symptoms was not a focus of the present
study and the overall symptom-focused outcomes of the
treatment program have been reported elsewhere [31].
Nonetheless, the relatively small clinical magnitude of
improvement in PTSD symptoms is noteworthy and
may be reflective of the complexity of clients who
attended the program in that most had previously not
benefitted from treatment in other services. Alterna-
tively, it may indicate that subset of participants did not
receive a full course of exposure-based therapy in their
individual sessions. Unfortunately, we lack the data to
determine if this was the case. We relied on a single
measure of personal wellbeing, albeit one that has been
validated in the Australian community and has sound
psychometric properties. It may be that measures of
Quality of Life across multiple life domains would detect
improvements related to more specific areas of daily liv-
ing. We were also not able to quantify the extent to
which the residential treatment program targeted per-
ceptions of personal wellbeing as opposed to PTSD
symptoms. The relatively high rate of program partici-
pants supported by funding (workers compensation
schemes, Department of Veterans’ Affairs and Depart-
ment of Defence) and the high rate of follow-up attrition
(64% of the sample attending the 9-month follow-up)
suggests that the findings may not generalize to other
studies and settings, although we believe it is reflective
of the routine setting in which the study was conducted.
Finally, our study did not include a control group or
randomized allocation to treatment and control condi-
tions precluding causal inferences about the role of
treatment in changes in personal wellbeing.
Conclusions
Extending the benefits of PTSD treatments beyond a
narrow focus on symptomatic improvement is important
for helping individuals with PTSD to enhance their lives.
The present results highlight how levels of personal
wellbeing are typically low in individuals with PTSD and
may only improve to a small extent during and following
an intensive residential trauma-focused treatment pro-
gram. Further research should consider the most effect-
ive pathways for enhancing personal wellbeing, whether
these be by improving symptoms or through approaches
that have a separate focus.
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